Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Shigdar

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Cancer Science|February 2, 2011
RNA aptamer against a cancer stem cell marker epithelial cell adhesion moleculeSarah Shigdar, Jia Lin, Yan Yu, et al.
Cancers|September 9, 2023
Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?Breanna Giles, Maryam Nakhjavani, Andrew Wiesa, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2018
Radiolabelled Aptamers for Theranostic Treatment of CancerUmair Khalid, Chris Vi, Justin Henri, et al.
British Journal of Haematology|August 4, 2011
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignanciesSarah Shigdar, Alister C Ward, Abhijit De, et al.
Nanoscale|August 6, 2015
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticlesLijue Chen, Xiaodong She, Tao Wang, et al.
International Journal of Nanomedicine|March 5, 2014
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cellsLei Li, Dongxi Xiang, Sarah Shigdar, et al.
Molecules (Basel, Switzerland)|December 1, 2017
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection ProceduresKamal Rahimizadeh, Hadi AlShamaileh, Milena Fratini, et al.
Biology|May 27, 2023
The Diagnostic Potential of RNA Aptamers against the NS1 Protein of Dengue Virus Serotype 2Ramesh Thevendran, Sivalingam Rogini, Glenn Leighton, et al.
Therapeutic Delivery|July 28, 2012
Cancer stem cell targeting: the next generation of cancer therapy and molecular imagingSarah Shigdar, Jia Lin, Yong Li, et al.
Nucleic Acid Therapeutics|February 7, 2020
Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor CellsJoanna Macdonald, Delphine Denoyer, Justin Henri, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Cancer Science|February 2, 2011
RNA aptamer against a cancer stem cell marker epithelial cell adhesion moleculeSarah Shigdar, Jia Lin, Yan Yu, et al.
Cancers|September 9, 2023
Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?Breanna Giles, Maryam Nakhjavani, Andrew Wiesa, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2018
Radiolabelled Aptamers for Theranostic Treatment of CancerUmair Khalid, Chris Vi, Justin Henri, et al.
British Journal of Haematology|August 4, 2011
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignanciesSarah Shigdar, Alister C Ward, Abhijit De, et al.
Nanoscale|August 6, 2015
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticlesLijue Chen, Xiaodong She, Tao Wang, et al.
International Journal of Nanomedicine|March 5, 2014
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cellsLei Li, Dongxi Xiang, Sarah Shigdar, et al.
Molecules (Basel, Switzerland)|December 1, 2017
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection ProceduresKamal Rahimizadeh, Hadi AlShamaileh, Milena Fratini, et al.
Biology|May 27, 2023
The Diagnostic Potential of RNA Aptamers against the NS1 Protein of Dengue Virus Serotype 2Ramesh Thevendran, Sivalingam Rogini, Glenn Leighton, et al.
Therapeutic Delivery|July 28, 2012
Cancer stem cell targeting: the next generation of cancer therapy and molecular imagingSarah Shigdar, Jia Lin, Yong Li, et al.
Nucleic Acid Therapeutics|February 7, 2020
Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor CellsJoanna Macdonald, Delphine Denoyer, Justin Henri, et al.
Pageof 6